Managing Patients With Pancreatic Cystic Lesions

David Loren, MD, Thomas Jefferson University, shares data on the molecular test, PancraGen, which helps identify false negative cases that could be missed by first-line tests like imaging, cytology and fluid chemistry.

2017-12-12T13:06:43+00:00